Table 2.
Variable (nmol/g) | Controla | LPS | GSP + LPS | Abx + GSP + LPS | p -value |
---|---|---|---|---|---|
Total bile acid | 547, 45.8ab | 621, 49.9a | 583, 21.2a | 447, 39.6b | 0.03 |
Unconjugated bile acid | 539, 44.8ab | 608, 49.7a | 571, 21.3a | 430, 38.6b | 0.02 |
Conjugated bile acid | 8.21, 1.12c | 13.2, 1.26b | 11.9, 1.34b | 17.3, 1.17a | <0.01 |
Cholic acid | 71.6, 2.80a | 78.5, 10.3a | 57.1, 10.9a | 28.5, 4.73b | <0.01 |
Chenodeoxycholic acid | 4.57, 0.88b | 7.89, 0.86b | 22.9, 3.01a | 3.75, 0.72b | <0.01 |
ω-muricholic acid | 158, 22.8 | 194, 28.2 | 144, 18.0 | 170, 23.9 | 0.52 |
α-muricholic acid | 55.2, 5.73ab | 70.4, 5.47a | 63.9, 7.96ab | 46.3, 7.28b | 0.09 |
β-muricholic acid | 77.5, 8.32 | 97.1, 12.4 | 90.8, 13.3 | 119, 16.3 | 0.19 |
Deoxycholic acid | 85.7, 8.79a | 106, 9.86a | 92.1, 8.59a | 28.5, 5.25b | <0.01 |
Lithocholic acid | 11.1, 1.29b | 13.2, 0.75b | 47.4, 5.10a | 5.56, 2.40b | <0.01 |
Ursodeoxycholic acid | 6.39, 0.92b | 8.07, 1.47ab | 9.99, 0.48a | 1.77, 0.44c | <0.01 |
Taurocholic acid | 2.87, 0.71b | 3.26, 0.62b | 2.01, 0.25b | 7.43, 0.54a | <0.01 |
Taurochenodeoxycholic acid | 0.16, 0.02b | 0.17, 0.07b | 0.29, 0.06b | 0.52, 0.07a | <0.01 |
Tauro-ω-muricholic acid | 2.31, 0.22b | 3.71, 0.49a | 3.55, 0.37ab | 4.43, 0.54a | 0.02 |
Tauro-α-muricholic acid | 2.17, 0.19b | 3.44, 0.38ab | 3.18, 0.52ab | 3.85, 0.48a | 0.06 |
Tauro-β-muricholic acid | 0.02, 0.00b | 0.03, 0.01b | 0.03, 0.01b | 0.27, 0.03a | <0.01 |
Taurodeoxycholic acid | 0.30, 0.06b | 0.49, 0.08ab | 0.58, 0.16a | 0.01, 0.00c | <0.01 |
Taurolithocholic acid | 0.06, 0.01b | 0.09, 0.02b | 0.16, 0.03a | 0.01, 0.00c | <0.01 |
Tauroursodeoxycholic acid | 0.11, 0.02a | 0.14, 0.02a | 0.13, 0.02a | 0.00, 0.00b | <0.01 |
In each row, means with the same letter represented no significant differences.
aControl, control group that oral gavaged with physiological saline before i.p. PBS injection; LPS, a LPS injection group that oral gavaged with physiological saline before i.p. LPS injection; GSP + LPS, a GSP administration group that oral gavaged with 250 mg/kg GSP before i.p. LPS injection; Abx + GSP + LPS, an antibiotic group that given a mixture of antibiotics in drinking water before the Experiment 1, and then coupled with GSP before i.p. LPS injection. n = 6–7.
BA, bile acid.